Soma Pharmacy Blognews

Swine Flu Shot Gives Fast Protection Adults will be protected from swine flu 8 to 10 days after getting a single shot of the H1N1 swine flu vaccine, U.S. trials show. Results of child studies will come in 2 weeks.

FDA OKs New Ovarian Cancer Blood Test Called OVA1 The FDA today approved a blood test called OVA1 to help detect ovarian cancer in a pelvic mass that is already known to require surgery.

STD Linked to Prostate Cancer Infection with a common sexually transmitted disease (STD) may make men more vulnerable to the most deadly form of prostate cancer, new research suggests.

‘Devil’s Dung’ Plant May Fight Swine Flu A plant commonly called “devil’s dung” for its foul smell may have flu-fighting properties.

Nasal Allergies May Dim Sex Life Having nasal allergies may dim people’s sex lives, researchers report.

Migraines Reduce Workplace Productivity Whether sufferers stay at home or go to work, migraines are a major, largely unrecognized, cause of lost workplace productivity, new research suggests.

Takeda, Millennium Initiate Phase II Trial For TAK-700 To treat patients with advanced prostate cancer

Lilly’s Cymbalta Maintains Reduction In Chronic Low Back Pain Study designed to evaluate long-term maintenance of effect in patients with chronic low back pain, taking duloxetine 60mg or 120mg once daily

IRIN examines report on varying cost of ARVs for countries with similar socioeconomic status IRIN examines a recent report (.pdf) that found varying price rates countries pay for antiretrovirals (ARVs) – with “some nations … paying up to three times more for the life-prolonging medicines than others with similar HIV prevalence and income levels.”

FDA accepts Merz Pharmaceuticals’ premarket approval application for Belotero Balance Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz’s premarket approval (PMA) application for Belotero(R) Balance.